Lacto-N-fucopentaose-I-LNFP-I-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
Lacto-N-fucopentaose-I-LNFP-I-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
Lacto-N-fucopentaose-I-LNFP-I-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
Lacto-N-fucopentaose-I-LNFP-I-DataSheet-生命科學(xué)試劑-MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemELacto-N-fucopentaoseICat.No.:HY-W019806CASNo.:7578-25-8Synonyms:LNFPI分?式:C??H??NO??分?量:853.77作?靶點(diǎn):EndogenousMetabolite;CDK;ReactiveOxygenSpecies;Apoptosis;Enterovirus;Bacterial作?通路:MetabolicEnzyme/Protease;CellCycle/DNADamage;Immunology/Inflammation;NF-κB;Apoptosis;Anti-infection儲(chǔ)存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性Lacto-N-fucopentaoseI(LNFPI)?種?母乳寡糖(HMO),具有抗病毒和抗活性。Lacto-N-fucopentaoseI通過(guò)減少?蛋?VP1來(lái)阻斷病毒吸附,增加CDK2、減少cyclinE恢復(fù)細(xì)胞周期S期的阻滯。Lacto-N-fucopentaoseI抑制病毒感染的細(xì)胞凋亡(apoptosis)。Lacto-N-fucopentaoseI也抑制ROS的產(chǎn)?。Lacto-N-fucopentaoseI還可以調(diào)節(jié)腸道群響免疫系統(tǒng)發(fā)育。IC50&TargetHumanEndogenousMetaboliteCDK2/cyclinE體外研究Lacto-N-fucopentaoseI(25-3200μg/mL;48h)exhibitscertaincytotoxicityat3200μg/mLbutnotoxicreactionbelow1600μg/mL[1].Lacto-N-fucopentaoseI(25-1600μg/mL;14-18h)canprotectEV71-infectedRDcellsfromdeath[1].Lacto-N-fucopentaoseI(100-400μg/mL;16h)decreasesmarkedlymRNAlevelsofVP1andROSproductioninEV71-infectedRDcellsat400μg/mL;leadstotherecoveryofEV71-inducedSphasearrestinRDcells[1].Lacto-N-fucopentaoseI(100and200μg/mL;3days)inhibitscellapoptosisinCaenorhabditiselegans;significantlydecreasesthelevelsofEgl-1,Ced-3andCed-4[1].Lacto-N-fucopentaoseIcanreducetheabundanceofSphingobacterium,StenotrophomonasandAchromobacter;canincreasetheabundanceofMicromonospora,Vibrio,Acidibacter,Gaiella,Devosia,Steroidobacter,Variibacter,Dactylosporangium,RB41,Pir4_lineage,Pirellula,Haliangium,Roseiflexus,Pedomicrobium,andBradyrhizobium.CellViabilityAssay[1]1/2MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemECellLine:RDcellsConcentration:25,50,100,200,400,800,1600and3200μg/mLIncubationTime:48hResult:Exhibitedcertaincytotoxicityat3200μg/mLbutnotoxicreactionbelow1600μg/mL.RT-PCR[1]CellLine:RDcells(infectedwithEV71)Concentration:100,200and400μg/mLIncubationTime:16hResult:DecreasedmarkedlymRNAlevelsofVP1onlyat400μg/mL.ApoptosisAnalysis[1]CellLine:RDcells(infectedwithEV71)Concentration:100,200and400μg/mLIncubationTime:16hResult:Decreasedtherateofcellsinearlyapoptosisto10.9%±1.26%at400μg/mL,whiletheuntreatedEV71groupwas27.7%±2.13%.Significantlyinhibitedtheactivityofcaspase-3,caspase-8andcaspase-9.RecoveredthedecreasedmRNAexpressionofPAPR,NF-κBandBcl-2andproperlyregulatedBadandFasintotheirnormallevels.CellCycleAnalysis[1]CellLine:RDcells(infectedwithEV71)Concentration:100,200and400μg/mLIncubationTime:12hResult:RescuedEV71-inducedSphasearrest,whichpromotedthetransitionoftheG1phasetotheSphase.REFERENCES[1].GaoX,etal.FucosylatedoligosaccharideLacto-N-fucopentaoseIamelioratesenterovirus71infectionbyinhibitingapoptosis.FoodChemX.2022Feb4;13:100244.McePdfHeight2/2MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemECaution:Producthasnotbeenfullyvalidate

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論